SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-066867
Filing Date
2022-06-01
Accepted
2022-06-01 07:05:33
Documents
8
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2217176d1_6k.htm 6-K 11562
2 EXHIBIT 99.1 tm2217176d1_ex99-1.htm EX-99.1 22456
3 EXHIBIT 99.2 tm2217176d1_ex99-2.htm EX-99.2 25647
4 EXHIBIT 99.3 tm2217176d1_ex99-3.htm EX-99.3 77862
5 EXHIBIT 99.4 tm2217176d1_ex99-4.htm EX-99.4 54071
6 GRAPHIC tm2217176d1_ex99-2img001.jpg GRAPHIC 3218
7 GRAPHIC tm2217176d1_ex99-2img002.jpg GRAPHIC 3426
8 GRAPHIC tm2217176d1_ex99-3img001.jpg GRAPHIC 4433
  Complete submission text file 0001104659-22-066867.txt   208396
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 22985943
SIC: 2834 Pharmaceutical Preparations